HER2+ Breast Cancer: Applying Recent Data Updates at ASCO 2024 into Clinical Practice - Episode 12
Unmet Needs and Future Direction in HER2+ Breast Cancer
Joyce A. O'Shaughnessy, MD, Melinda L. Telli, MD, Aditya Bardia, MD, MPH, Ian Krop, MD, PhD, Kandace McGuire, MD The panel looks to the future landscape for HER2+ breast cancer, highlighting emerging treatment practices and currently unmet needs.
Video content above is prompted by the following:
- Please provide your closing thoughts about current and future management in HER2+ early stage mBC and HER2-low and ultra-low mBC.